Author and journalist Maryn McKenna in her “Superbug” blog on Wired.com examines U.S. spending on drug-resistant pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). She examines data presented by Eli Perencevich of the University of Iowa and colleagues at the World HAI Forum, which looked at how much of the National Institute of Allergy and Infectious Diseases’ budget went to the problem of drug-resistant diseases versus other infectious diseases. “They found the answer to be: Not very much,” she writes.
Programs, Funding & Financing
“The U.S. Agency for International Development, as it cracks down on vendor impropriety, has more than doubled the number of companies and nonprofit groups it has suspended or debarred from receiving new contracts,” the Washington Post reports in an article focusing on the agency’s suspension of government grants in March to the Washington-based nonprofit Academy for Educational Development (AED).
“Germany is unblocking half of the funding it withheld from” the Global Fund to Fight AIDS, Tuberculosis and Malaria “following revelations of corruption earlier this year,” the Associated Press reports.
“India’s Prime Minister Manmohan Singh on Monday hailed the country’s success in slashing new HIV/AIDS infections by half in the past decade, but warned against complacency,” Agence France-Presse reports. Speaking at a conference on AIDS in New Delhi, Singh said the country’s HIV prevention program “can justifiably claim a measure of success,” but “there should be no room for complacency,” as an estimated 2.4 million Indians are living with the disease, according to AFP.
As a severe drought affecting Somalia, Kenya, Djibouti and Ethiopia forces more people into refugee camps, donor fatigue is harming aid agencies’ abilities to work in the Horn of Africa, because “these recurrent droughts used to happen every 5-10 years but what we see now is it basically every other year … an indication of climate change conditions,” Michael Klaus, UNICEF spokesperson for east and southern Africa, told Reuters in an interview (Gachenge, 7/2).
Andrew Harmer, a research fellow at the London School of Hygiene and Tropical Medicine, in this globalhealthpolicy.net blog post lays out the global health “winners” and “losers” in terms of funding. “Two things will help secure future funds: show donors that what they fund delivers results, and make it clear…
Thirty years have passed since the first reported case of AIDS, and “we now have an unprecedented opportunity, based on solid scientific data, to control and ultimately end the AIDS pandemic,” after decades of the idea being “a distant aspiration because we lacked sufficient evidence-based tools to convert the hope to reality,” Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, writes in a Science editorial.
In a Washington Times opinion piece, Rep. Jason Chaffetz (R-Utah) points to recent developments and experiences that have led him to conclude that “vast amounts of U.S. aid money is being spent with little documentation or verification of quantifiable results.”
Inter Press Service looks at funding for U.N. Women six months after the organization launched. U.N. Secretary-General Ban Ki-moon “set an initial target of 500 million dollars as the proposed annual budget for the new gender-empowered body. But nearly six months later, the voluntary funding for U.N. Women (UNW) from the 192 member states has remained painfully slow,” IPS writes.
“The U.N. World Food Programme (WFP) is being forced by a funding shortfall to cut its recovery programmes in nearly half of Afghanistanâ€™s 34 provinces, a spokesperson said,” just as the country prepares for expected food shortages over the coming months, IRIN reports.